Heart radiation treatment planning for ventricular tachycardia
Part of Heart & circulation clinical trials.
This study tests a new way to plan and deliver precise radiation (radioablation) to the heart to treat a dangerous rapid heartbeat called monomorphic ventricular tachycardia. It aims to improve imaging and treatment planning so that radiation can be targeted more safely and effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You need to have a heart condition called ischemic cardiomyopathy (weakened heart muscle due to blocked arteries).
- Your heartbeat problem must be a specific type called monomorphic ventricular tachycardia (VT).
- Your doctor must have referred you to this trial.
- You cannot have severe kidney disease (eGFR ≤ 30), and you must not have had a bad allergic reaction to CT contrast dye before.
- You cannot be pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a precise, one-time radiation treatment (usually used for cancer) can reduce episodes of a dangerous rapid heartbeat called ventricular tachycardia. It may offer an option for people who have not been helped by other treatments.
This trial studies a non-invasive treatment using focused radiation to target the heart tissue causing dangerous heart rhythms. It may be an option for people who have already had a catheter ablation but still get episodes of ventricular tachycardia.
This trial studies a new way to treat a dangerous fast heart rhythm (ventricular tachycardia) using targeted radiation to the heart. It is for people who have already tried other treatments and are still having symptoms.
This study tests if targeted radiation therapy can help people with a serious heart rhythm problem called ventricular tachycardia (VT) that hasn't gotten better with other treatments. It aims to see if this approach can reduce dangerous heart rhythm episodes.
This study tests a targeted form of radiation therapy to stop a dangerous, repeat heart rhythm called ventricular tachycardia. It’s for people whose rhythm keeps coming back even after standard treatments like antiarrhythmic medications and prior heart procedure studies.
This trial compares two treatments—radiation therapy or catheter ablation—for people with structural heart disease who have a type of fast heart rhythm called ventricular tachycardia. It aims to see which approach works better to prevent repeat episodes.
Hear when a new Ventricular Tachycardia, Monomorphic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.